Image-guided hypofractionated small volume radiotherapy of non-small cell lung cancer - Feasibility and clinical outcome

Onkologie

Volumn 35, Issue 7-8, 2012, Pages 408-412

  Janssen, Stefan ^a   Dickgreber, Nicolas J ^a   Koenig, Carolin ^a   Bremer, Michael ^a   Werner, Martin ^a   Karstens, Johann H ^a   Welte, Tobias ^a   Meyer, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Lung cancer; Outcome; radiotherapy; Stereotactic extracranial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMAGE GUIDED HYPOFRACTIONATED RADIOTHERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OVERALL SURVIVAL; PNEUMONIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RADIOTHERAPY, CONFORMAL; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864618913     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000340064     Document Type: Article

References (26)

1. Chang MY, Sugarbaker DJ: Surgery for early stage non-small cell lung cancer. Semin Surg Oncol 2003;21:74-84.
2. Martini N, Bains MS, Burt ME, et al.: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
3. Dosoretz DE, Galmarini D, Rubenstein JH, et al.: Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507-516.
4. Qiao X, Tullgren O, Lax I, et al.: The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1-11.
5. Onishi H, Shirato H, Nagata Y, et al.: Hypofractionated stereotactic radiotherapy (hypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;3:94-100.
6. Timmermann RD, Kavanagh BD, Cho LC, et al.: Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007;25:947-952.
7. Baumann P, Nyman J, Hoyer M, et al.: Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with tereotactic body radiotherapy. J Clin Oncol 2009;27:3290-3296.
8. Bral S, Gevaert T, Linthout N, et al.: Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: Results of a Phase II trial. Int J Radiat Oncol Biol Phys 2011;80:1343-1349.
9. Ricardi U, Filippi AR, Guameri A, et al.: Stereotactic body radiation therapy for early stage nonsmall cell lung cancer: Results of a prospective trial. Lung Cancer 2010;68:72-77.
10. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al.: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682.
11. Guckenberger M, Baier K, Polat B, et al.: Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 2010;97:65-70.
12. Hara R, Itami J, Kondo T, et al.: Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002;63:159-163.
13. Hof H, Herfarth K, Münter M, et al.: Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 56:335-341.
14. Nakagawa K, Aoki Y, Tago M, et al.: Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumor: Original reseach in the treatment of thoracic neoplams. Int J Radiat Oncol Biol Phys 2000;48: 449-457.
15. Onimaru R, Shirato H, Shimizu S, et al.: Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic ung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135.
16. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidlines to evaluate the response to treatment in solid tumors (RECIST guidlines). J Natl Cancer Inst 2000;92:205-216.
17. Manser R, Wright G, Hart D, et al.: Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 2005;1:CD004699.
18. Raz DJ, Zell JA, Ou SH, et al.: Natural history of stage I non-small cell lung cancer: Implications for early detection. Chest 2007;132:193-199.
19. Rowell NP, Williams CJ: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review. Thorax 2001;56: 628-638.
20. Wulf J, Hadinger U, Oppitz U, et al.: Stereotactic radiotherapy of targets in lung and liver. Strahlenther Onkol 2001;177:645-655.
21. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al.: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70:685-692.
22. A Randomized Clinical Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer (ROSEL). NIH Clinical Trials database. (NCT00687986 and NCT00840749).
23. Lopez-Encuentra A, Garcia-Lujan R, Rivas JJ, et al.: Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 2005;79:974-979.
24. Zimmermann FB, Geinitz H, Schill S, et al.: Stereotactic hypofractionated radiotherapy in stage I (T1-2N0M0) non-small-cell lung cancer (NSCLC).Acta Oncol 2006;45:796-801.
25. Carey Sampson M, Katz A, Constine LS: Stereotactic body radiation therapy for extracranial oligometastases: Does the sword have a double edge? Semin Radiat Oncol 2006;16:67-76.
26. Kimura T, Matsuura K, Murakami Y, et al.: CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006; 66:483-491.